Cost Savings of Using Updated Thai Red Cross Intradermal Regimen in a High-Throughput Anti-Rabies Clinic in New Delhi, India

• Published in: Tropical medicine and infectious disease 2019-03, Vol.4 (1), p.50
• Main Authors: Kundu, Bijit Kumar, Meshram, Girish Gulab, Bhargava, Shrinath, Meena, Omprakash
• Format: Article
• Language: English
• Subjects: cost savings; Essen regimen; post-exposure prophylaxis; rabies; updated Thai Red Cross regimen
• ISSN: 2414-6366; 2414-6366
• DOI: 10.3390/tropicalmed4010050

Replacement of the Essen intramuscular (EIM) by the updated Thai Red Cross intradermal (UTRCID) regimen for rabies post-exposure prophylaxis (PEP), in high-throughput hospitals of India, has been advocated since 2006 thanks to its cost-effectiveness. However, several anti-rabies clinics in India and other parts of the world have not initiated this switchover of regimens because of the paucity of financial literature, generated in realistic settings, regarding the same. We calculated the procurement costs of various items required for providing rabies vaccinations via the EIM regimen and UTRCID regimen, on an annual basis, a year before and after the switchover. From a healthcare provider's perspective, the cost of vaccination per patient was calculated to be 5.60 USD for the EIM regimen and 2.40 USD for the UTRCID regimen. The switchover to the UTRCID regimen from the EIM regimen reduced the financial burden of the rabies vaccination by almost 60%. Procurement of vaccine vials contributed to the majority of the cost (>94%) in both of the regimens. Procurement of syringes with fixed needles contributed negligibly (